Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2016 - 2025)

Enanta Pharmaceuticals' Asset Utilization Ratio history spans 13 years, with the latest figure at 0.22 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 19.55% year-over-year to 0.22; the TTM value through Dec 2025 reached 0.22, up 19.55%, while the annual FY2025 figure was 0.2, 23.26% up from the prior year.
  • Asset Utilization Ratio reached 0.22 in Q4 2025 per ENTA's latest filing, down from 0.22 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.24 in Q1 2023 to a low of 0.17 in Q4 2023.
  • Average Asset Utilization Ratio over 5 years is 0.2, with a median of 0.21 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 42.19% in 2021, then rose 28.74% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2021, then grew by 7.4% to 0.23 in 2022, then decreased by 27.22% to 0.17 in 2023, then increased by 11.09% to 0.18 in 2024, then grew by 19.55% to 0.22 in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Asset Utilization Ratio are 0.22 (Q4 2025), 0.22 (Q3 2025), and 0.21 (Q2 2025).